New Products In Brief
This article was originally published in The Gray Sheet
Executive SummaryXience/Promus approved for small vessels
You may also be interested in...
The unit and its former CEO admitted to selling knee-replacement instruments even after FDA rejected a 510(k), prior to OtisMed being acquired by Stryker in 2009. The legal resolution comes with about $80 million in fines and possible jail time for the former CEO. Also, Stryker has agreed to conduct an audit on the FDA approval status of devices in its portfolio.